PubMed Health⌕ Search

Biomedical subjects

M L Colglazier

Publications and source records attributed to M L Colglazier.

At least 19 recordsLinked to original sources
PubMed1996

Prologue for a synoptic catalog: combining a hospital library catalog and a bookseller's catalog.

This article introduces the synoptic catalog, a computerized combination of a hospital library catalog and a bookseller's catalog. Majors Scientific Books and Richmond Memorial Hospital Libraries in Virginia collaborated to develop the model. A logical evolution in catalog theory and practice, the design expands the identification, collocation, and evaluation functions of the traditional library catalog. This article explains the procedures and specifications, including system requirements, record mapping, design details, scope, record transmission, timing, record importing, and file maintenance. The result is a single-interface catalog providing simultaneous and consistent searching of combined information databases. Bookseller records in the synoptic catalog can be modified to indicate library ownership. The synoptic catalog design supports cost-effective collection development and focuses on actual information needs of library users. This report discusses user convenience, budget requirements, publisher advertising, collection development, productivity, and library-bookseller relations. User response to the catalog has been favorable, but improvements are needed.

Catalogs, Library↗
PubMed1982

Glucose metabolism of Haemonchus contortus adults: effects of thiabendazole on susceptible versus resistant strain.

Analyses of the in vitro glucose metabolism of Haemonchus contortus adults have confirmed a complex series of end-products: ethanol, n-propanol, propionate, acetate, and CO2 as the major end-products of catabolism. No difference in end-product accumulation was seen between the cambendazole sensitive (BPL) and cambendazole resistant (CR) strains. Thiabendazole (5 mM) in vitro depressed ethanol, propanol, acetate, and propionate accumulation by approximately 42% in the BPL strain. However, in the resistant strain (CR), these end-product accumulations increased by 50% when the worms were exposed to drug in vitro and 80% when exposed in vivo. Resistance manifested by the CR strain appeared to be associated with the ability to increase its carbon flow in the presence of thiabendazole.

1-Propanol↗
PubMed1981

Inheritance of cambendazole resistance in Haemonchus contortus.

Fourth-molt larvae (M4) of cambendazole-resistant (CBZ-R) and cambendazole-susceptible (BPL) strains of Haemonchus contortus were recovered from donor lambs and inoculated orally into source lambs to effect mating in 2nd lamb. Eggs produced by these parasitic matings were collected, cultured, and inoculated into lambs to compare the anthelmintic activity of cambendazole (CBZ), given at a dose rate of 20 mg/kg, against the F1 adults with its activity against the 2 parenteral strains (CBZ-R and PBL). In 2 replications, CBZ was 94% and 99% efficacious against the progeny of the cross matings and 91% and 95% against the BPL strain; CBZ was only 39% and 42% efficacious against the CBZ-R strain. In 1 test of F2 progeny of the reciprocal matings, CBZ was 81.2% efficacious against the F2 adults, whereas CBZ was 97.5% efficacious against the BPL strain and 37% against the CBZ-R strain. The results indicated that heredity of resistance to CBZ in H contortus is not sex-linked and is probably a result of a heterozygous recessive allele. The infective larvae of the CBZ-R groups in these 3 trials were from the 20th and 24th passages through lambs without exposure to any anthelmintics, yet the anthelmintic activity of CBZ ranged from 37% to 42%, indicating that there had been no reversion to susceptibility.

Alleles↗
PubMed1980

Chemoprophylaxis with diamfenetide against experimental infections of Fasciola hepatica in ruminants.

In limited trials against experimentally induced Fasciola hepatica infections, diamfenetide (N,N'-[oxybis(2,1-ethanediyloxy-4,1-phenylene)]bisacetamide) showed potential value for the prevention of acute fascioliasis in sheep and cattle. When given at a dosage of 10 mg/kg of body weight, diamfenetide was 87% effective in preventing establishment of F hepatica infections in sheep that were given the drug daily for 14 days, and was 96% effective in sheep that were given the drug for 21 days. Infective cysts (4 doses of 150 each) were given by capsule at 2-day intervals during the first week of medication. In additional trials, initial single large doses (40 to 100 mg/kg of body weight) given in conjunction with small doses each day (5 to 40 mg/kg), did not augment chemoprophylactic action. Signs of toxicosis attributable to diamfenetide were not observed. The severity of hepatic lesions ascribable to F hepatica correlated well with the degree of fluke control achieved. Small doses of diamfenetide given each day were less effective in calves than in sheep. Nevertheless, when given at dosages of 30 mg/kg daily for 11 days, the drug was 89% effective in preventing the development of F hepatica infections in two calves which were given infective cysts (4 X 100) by capsule at 2-day intervals during the first week of medication. Small doses of diamfenetide given daily were effective in preventing the establishment of F hepatica infections in ruminants.

Acetanilides↗
PubMed1979

Critical anthelmintic trials in ponies with oxfendazole and caviphos and concomitant studies on the spontaneous elimination of small strongylids.

The efficacy of the benzimidazole, oxfendazole, and the organophosphate, caviphos, against gastrointestinal parasites of ponies was evaluated by the critcial test method. Oxfendazole (10 mg/kg of body weight) given in single oral doses was 100% effective against adult large strongylids (Strongylus vulgaris, Strongylus edentatus, and Strongylus equinus), 99% effective against adult small strongylids, and 97% effective against 4th-stage small strongylids (genera identified in order of frequency: Cylicostephanus, Cyathostomum, Cylicocyclus, Triodontophorus, Poteriostomum, Oesophagodontus, Cylicodontophorus, Gyalocephalus, and Craterostomum). Caviphos (40 mg/kg of body weight) admixed in the grain ration (horse crunch) was 89% effective against adult large strongylids (S vulgaris and S edentatus) and 99% effective against adult small strongylids (genera identified earlier in order of frequency above), but only 35% effective against 4th-stage small strongylids. Both drugs were effective (100%) against adult and immature pinworms (Oxyuris equi) but ineffective against Habronema spp and Draschia megastoma. Oxfendazole was only 11% effective against stomach bots (Gasterophilus spp); caviphos was 73% effective against these species. During a three-day pretreatment interval, about 34% of the total population of small strongylids was lost spontaneously from the 29 ponies.

Animals↗
PubMed1977

Albendazole as a fasciolicide in experimentally infected sheep.

The new drug albendazole (methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate) was tested in 90 sheep experimentally infected with Fasciola hepatica. Dose rates of 10, 15, and 20 mg/kg of body weight were active against adult flukes, with efficacies of 98, 95, and 100% respectively. The drug was less active against immature F hepatica at 3 weeks after sheep were inoculated. The drug given at dose rates of 20, 30, 40, and 50 mg/kg had efficacies 24, 47, 63, and 76%. Flukes were not found at posttreatment hour 48 in bile ducts of sheep given a dose of 20 mg/kg. Evidence of drug toxicity was not seen.

Animals↗
PubMed1977

Critical anthelmintic trials in ponies with four benzimidazoles: mebendazole, cambendazole, fenbendazole, and albendazole.

The comparative efficacy of four benzimidazoles against gastrointestinal parasites of ponies was evaluated by the critical test method. Mebendazole (8.8 mg/kg), cambendazole (20 mg/kg), fenbendazole (5 mg/kg), and albendazole (2.5 and 5 mg/kg) given in single oral doses were highly effective against adult large strongylids (Strongylus vulgaris, S. endentatus, S. equinus) and adult small strongylids (genera identified in order of frequency: Cylicostephanus, Cylicocyclus, Cyathostomum, Triodontophorus, Poteriostomum, Oesophagodontus, Cylicodontophorus, Gyalocephalus, and Craterostomum). Limited data indicated that all benzimidazoles were completely effective against adult Oxyuris equi and 95 to 100% effective against the 4th stage larvae. There was activity also against the large roundworm, Parascaris equorum, although the low levels of infection and skew distribution among the test animals did not permit a definitive determination of efficacy. Habronema muscae, Draschia megastoma, and Trichostrongylus axei were found in digests of the stomach but none were recovered in the feces after treatment; percent efficacy for these species was not calculated. None of the benzimidazoles showed activity against stomach bots, Gasterophilus spp., and tapeworms, Anoplocephala spp. nor against immature large and small strongylids outside the lumen of the digestive tract.

Animals↗
PubMed1975

Oxibendazole: critical anthelmintic trials in equids.

The efficacy of oxibendazole against gastrointestinal parasites of horses was evaluated by the critical test method. Naturally infected ponies of various ages were given single oral doses of 5, 10, or 15 mg-kg of bodyweight. The drug was highly effective against adult large strongylids (Strongylus vulgaris, S edentatus, S equins), adult small strongylids (especially species of the genera Cylicostephanus, Cylicocyclus, Cyaathostomum, and Triodontophorus), and adult and larval stages of the large pinworm, Oxyuris equi. There was no apparent dose-related differences in efficacy. Oxibendazole was less effective against fourth-stage small strongylid larvae than it was against adults. The drug was inactive against stomach bots (Gasterophilus spp), tapeworms (Anoplocephala magna and A perfoliata), lungworms (Dictyocaulus arnfieldi), abdominal worms )Setaria equina), and mature or immature nematodes in locations other than the lumen of the gastrointestinal tract.

Animals↗